News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sera Prognostics Closes $1.4 Million Series A-1 Financing


1/4/2011 10:13:02 AM

SALT LAKE CITY, Jan. 4, 2011 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's health company developing diagnostic tests for early prediction of preterm birth and other pregnancy complications, today announced that it raised $1.4 million in Series A-1 financing. Sera is currently developing a simple blood test that measures proprietary biomarkers that are highly predictive of preterm birth risk.

Read at GlobeNewswire


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES